These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 31787905)
1. Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation. Gündüz D; Troidl C; Tanislav C; Rohrbach S; Hamm C; Aslam M Front Physiol; 2019; 10():1387. PubMed ID: 31787905 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. Aslam M; Schluter KD; Rohrbach S; Rafiq A; Nazli S; Piper HM; Noll T; Schulz R; Gündüz D J Physiol; 2013 Jan; 591(2):461-73. PubMed ID: 23090948 [TBL] [Abstract][Full Text] [Related]
3. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976 [TBL] [Abstract][Full Text] [Related]
4. Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Aslam M; Pfeil U; Gündüz D; Rafiq A; Kummer W; Piper HM; Noll T Br J Pharmacol; 2012 Jan; 165(1):208-22. PubMed ID: 21671901 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro. Aslam M; Idrees H; Ferdinandy P; Helyes Z; Hamm C; Schulz R Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328517 [TBL] [Abstract][Full Text] [Related]
6. The cAMP effectors PKA and Epac activate endothelial NO synthase through PI3K/Akt pathway in human endothelial cells. García-Morales V; Luaces-Regueira M; Campos-Toimil M Biochem Pharmacol; 2017 Dec; 145():94-101. PubMed ID: 28912066 [TBL] [Abstract][Full Text] [Related]
7. Compound C inhibits in vitro angiogenesis and ameliorates thrombin-induced endothelial barrier failure. Gündüz D; Klewer M; Bauer P; Tanislav C; Sedding D; Rohrbach S; Schulz R; Aslam M Eur J Pharmacol; 2015 Dec; 768():165-72. PubMed ID: 26522925 [TBL] [Abstract][Full Text] [Related]
8. cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation. Aslam M; Tanislav C; Troidl C; Schulz R; Hamm C; Gündüz D Physiol Rep; 2014 Oct; 2(10):. PubMed ID: 25344477 [TBL] [Abstract][Full Text] [Related]
9. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1. Aslam M; Gündüz D; Schuler D; Li L; Sharifpanah F; Sedding D; Piper HM; Noll T Cardiovasc Res; 2011 Nov; 92(2):276-86. PubMed ID: 21816966 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609 [TBL] [Abstract][Full Text] [Related]
12. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619 [TBL] [Abstract][Full Text] [Related]
13. Epac agonist improves barrier function in iPSC-derived endothelial colony forming cells for whole organ tissue engineering. Yuan Y; Engler AJ; Raredon MS; Le A; Baevova P; Yoder MC; Niklason LE Biomaterials; 2019 Apr; 200():25-34. PubMed ID: 30754017 [TBL] [Abstract][Full Text] [Related]
14. Exchange protein activated by cyclic adenosine monophosphate regulates the switch between adipogenesis and osteogenesis of human mesenchymal stem cells through increasing the activation of phosphatidylinositol 3-kinase. Tang Z; Shi D; Jia B; Chen J; Zong C; Shen D; Zheng Q; Wang J; Tong X Int J Biochem Cell Biol; 2012 Jul; 44(7):1106-20. PubMed ID: 22497928 [TBL] [Abstract][Full Text] [Related]
15. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway. Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463 [TBL] [Abstract][Full Text] [Related]
16. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells. Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733 [TBL] [Abstract][Full Text] [Related]
17. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. Laprise P; Langlois MJ; Boucher MJ; Jobin C; Rivard N J Cell Physiol; 2004 Apr; 199(1):32-9. PubMed ID: 14978732 [TBL] [Abstract][Full Text] [Related]
19. Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes. Mohd Fauzi F; John CM; Karunanidhi A; Mussa HY; Ramasamy R; Adam A; Bender A J Ethnopharmacol; 2017 Feb; 197():61-72. PubMed ID: 27452659 [TBL] [Abstract][Full Text] [Related]
20. Effect of melatonin on EGF- and VEGF-induced monolayer permeability of HUVECs. Yang L; Zhang Y; Ma Y; Du J; Gu L; Zheng L; Zhang X Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1178-H1191. PubMed ID: 30575440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]